Background: PAG/Cbp represents a ubiquitous mechanism for regulating Src family kinases by recruiting Csk to the plasma membrane, thereby controlling cellular activation. Since Src kinases are known oncogenes, we used RNA interference in primary human T cells to test whether the loss of PAG resulted in lymphocyte transformation.
Results: PAG-depletion enhanced Src kinase activity and augmented proximal T-cell receptor signaling; exactly the phenotype expected for loss of this negative regulator. Surprisingly, rather than becoming hyper-proliferative, PAG-suppressed T cells became unresponsive. This was mediated by a Fyn-dependent hyper-phosphorylation of the inhibitory receptor CTLA-4, which recruited the protein tyrosine phosphatase Shp-1 to lipid rafts. Co-suppression of CTLA-4 abrogates this inhibition and restores proliferation to T cells.
Conclusion: We have identified a fail-safe mechanism as well as a novel contribution of CTLA-4 to setting the activation threshold in T cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763844 | PMC |
| http://dx.doi.org/10.1186/1478-811X-11-28 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the Immunoresponse in Bladder Cancer Immunotherapy.
Cells
November 2024
Immunology Service, Virgen de la Arrixaca University Clinical Hospital (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
Bladder cancer (BC) represents a wide spectrum of diseases, ranging from recurrent non-invasive tumors to advanced stages that require intensive treatments. BC accounts for an estimated 500,000 new cases and 200,000 deaths worldwide every year. Understanding the biology of BC has changed how this disease is diagnosed and treated.
View Article and Find Full Text PDFHepatic and pulmonary macrophage activity in a mucosal challenge model of Ebola virus disease.
Front Immunol
December 2024
Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.
Background: The inflammatory macrophage response contributes to severe Ebola virus disease, with liver and lung injury in humans.
Objective: We sought to further define the activation status of hepatic and pulmonary macrophage populations in Ebola virus disease.
Methods: We compared liver and lung tissue from terminal Ebola virus (EBOV)-infected and uninfected control cynomolgus macaques challenged via the conjunctival route.
Enhancing Tumor Immunity with IL-12 and PD-1 Blockade: A Strategy for Inducing Robust Central Memory T Cell Responses in Resistant Cancer Model.
Antibodies (Basel)
November 2024
State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health and School of Life Sciences, Xiamen University, Xiamen 361102, China.
Although immune checkpoint inhibitors (ICIs) have demonstrated efficacy in treating advanced cancers, their therapeutic success remains limited for many patients, with initial responders often experiencing resistance and relapse. Interleukin-12 (IL-12) is a powerful cytokine for antitumor immunotherapy, enhancing both lymphocyte recruitment into tumors and immune cell activation. In this study, we successfully produced mouse interleukin-12 (mIL12) through eukaryotic recombinant expression.
View Article and Find Full Text PDFImmunological biomarkers and predictive model for recurrence of esophageal squamous cell carcinoma after combined immunotherapy and neoadjuvant chemotherapy.
Am J Cancer Res
October 2024
Oncology Department, Zhengzhou Universiy People's Hospital (Henan Provincial People's Hospital) Zhengzhou 450003, Henan, China.
Article Synopsis
- - The study aimed to explore how certain immune system markers before surgery relate to the chances of esophageal squamous cell carcinoma (ESCC) returning within three years after patients undergo immunotherapy and chemotherapy.
- - Researchers analyzed 348 ESCC patients, comparing those who experienced recurrence to those who did not, looking at various immunological factors and lifestyle choices that could impact recurrence risk.
- - Key findings indicated that higher levels of CD8+ and Perforin+ cells were linked to a lower recurrence risk, while certain proteins (like EGFR and PD-L1) correlated with a higher risk; a predictive model showed high accuracy for assessing recurrence based on these markers.
Th17/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target.
Front Oncol
October 2024
State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China.
Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid carcinoma. The most effective treatment for PTC is surgical resection, and patients who undergo surgery have good survival outcomes, but some patients have distant metastasis or even multiorgan metastases at the time of initial diagnosis. Distant metastasis is associated with poorer prognosis and a higher mortality rate.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!